Expert opinion on expanding anti-HBV treatment for chronic hepatitis B / 中华肝脏病杂志
Chinese Journal of Hepatology
;
(12): 131-136, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-928459
ABSTRACT
To meet the unmet medical needs and better reflect the new clinical evidence of chronic hepatitis B management, Chinese Society of Hepatology developed expert consensus on expanding diagnosis and treatment in China. The recommendations include to expand HBsAg screening in the population and HBV DNA detection by sensitive quantitative real-time PCR (qPCR), decrease the alanine aminotransferase (ALT) threshold for treatment of chronic hepatitis B, and promptly start antiviral therapy in the patients who are at risk of disease progression, and appropriately manage the patients with low level viremia.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
DNA, Viral
/
Hepatitis B, Chronic
/
Alanine Transaminase
/
Expert Testimony
/
Hepatitis B Surface Antigens
Type of study:
Practice guideline
Limits:
Humans
Language:
Chinese
Journal:
Chinese Journal of Hepatology
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS